Substitutes for Medigas New Oral Drops
Composition: Dicyclomine 10mg + Simethicone 40mg
Medigas New Oral Drops is out of stock right now
Good news — 4 medicines with the same composition are listed below and can be ordered instead.
You're viewing
Medigas New Oral Drops
Rapross Pharmaceuticals Pvt Ltd
₹109 Out of stock
View details Same composition & strength
1A like-for-like swap — identical active ingredients, same strength and form as Medigas New Oral Drops.
Yuflam-S Oral Drops
Yuventis Lifesciences
Simethicone40mg+1
₹80
Out of Stock Save ₹29 (27% off)
Same molecule — other strengths or forms
3Same active ingredient(s) but a different strength or form — check the strength matches your prescription.
About these molecules
Dicyclomine10mg
Full details →Dicyclomine is an antispasmodic agent used to treat irritable bowel syndrome (IBS). It works by relaxing intestinal muscles and relieving spasms. Dicyclomine's clinical relevance lies in its effectiveness for managing gastrointestinal discomfort. In summary, Dicyclomine is essential for treating IBS symptoms.
Simethicone40mg
Full details →Simethicone is an anti-foaming agent used to relieve symptoms of excess gas, such as bloating and discomfort in the gastrointestinal tract. It works by reducing the surface tension of gas bubbles, allowing them to coalesce and be expelled more easily. Simethicone is often used for conditions like flatulence, indigestion, and post-operative gas pain. It is generally safe and well-tolerated, with minimal side effects. In summary, Simethicone provides effective relief from gas-related discomfort.
Why a generic substitute?
Same active ingredient
A substitute has the exact same salt(s) — so it works the same way as the brand.
Often much cheaper
Generics can cost a fraction of the branded price for the identical molecule.
Quality-regulated
All medicines we list are from licensed sellers and meet the same standards.
Substitutes share the same active ingredients, but always confirm the strength and form with your doctor or pharmacist before switching — especially for chronic, prescription or narrow-therapeutic-index medicines.
